<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Elsulfavirine</id>
	<title>Elsulfavirine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Elsulfavirine"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Elsulfavirine&amp;action=history"/>
	<updated>2026-04-30T06:20:10Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Elsulfavirine&amp;diff=5804088&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Elsulfavirine&amp;diff=5804088&amp;oldid=prev"/>
		<updated>2024-05-20T06:06:37Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Elsulfavirine.svg|thumb|right]] &amp;#039;&amp;#039;&amp;#039;Elsulfavirine&amp;#039;&amp;#039;&amp;#039; is an [[antiretroviral drug]] used in the treatment of [[HIV/AIDS]]. It is a [[non-nucleoside reverse transcriptase inhibitor]] (NNRTI) that works by inhibiting the action of [[reverse transcriptase]], an enzyme crucial for the replication of [[HIV]].&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
Elsulfavirine targets the reverse transcriptase enzyme, which is essential for the conversion of viral [[RNA]] into [[DNA]]. By binding to the enzyme, elsulfavirine prevents the transcription process, thereby inhibiting the replication of the virus within the host cells.&lt;br /&gt;
&lt;br /&gt;
==Pharmacokinetics==&lt;br /&gt;
Elsulfavirine is administered orally and is metabolized in the liver. It has a long half-life, which allows for once-daily dosing. The drug is primarily excreted through the kidneys.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
Elsulfavirine is used in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. It is particularly useful in patients who have developed resistance to other NNRTIs.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of elsulfavirine include [[nausea]], [[headache]], and [[dizziness]]. Severe side effects may include [[hepatotoxicity]] and [[skin rash]]. Patients are advised to undergo regular monitoring of liver function tests while on this medication.&lt;br /&gt;
&lt;br /&gt;
==Drug Interactions==&lt;br /&gt;
Elsulfavirine may interact with other medications metabolized by the liver, including certain [[antifungal]]s, [[antibiotic]]s, and other antiretroviral drugs. It is important to inform healthcare providers of all medications being taken to avoid potential interactions.&lt;br /&gt;
&lt;br /&gt;
==Research and Development==&lt;br /&gt;
Elsulfavirine is currently under investigation for its efficacy and safety in various populations, including [[pregnant women]] and [[children]]. Ongoing studies aim to explore its potential in reducing the viral load and improving the quality of life for individuals living with HIV.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[HIV/AIDS]]&lt;br /&gt;
* [[Antiretroviral therapy]]&lt;br /&gt;
* [[Non-nucleoside reverse transcriptase inhibitor]]&lt;br /&gt;
* [[Reverse transcriptase]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
{{No external links}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Antiretroviral drugs]]&lt;br /&gt;
[[Category:HIV/AIDS]]&lt;br /&gt;
[[Category:Non-nucleoside reverse transcriptase inhibitors]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>